<H2>Louisiana Enacts New THC and CBD Regulations for 2025</H2>
<p>As we usher in 2025, Louisiana introduces transformative changes in its cannabis policy landscape. Effective January 1, 2025, the state lowers permissible levels of tetrahydrocannabinol (THC) and cannabidiol (CBD) in products from the previous 8 mg to a new limit of 5 mg. This regulatory adjustment aims to standardize potency across products sold in the Bayou State, ensuring safe consumption for its residents.</p>
<p>In a move indicative of stricter cannabis governance, gas stations are prohibited from selling THC and CBD products. Furthermore, the legal purchasing age for cannabis products has been increased to 21, aligning with national standards and fostering responsible use among young adults.</p>
<H2>California Moves Towards Permanent Hemp Product Restrictions</H2>
<p>The California Department of Public Health (CDPH) announced its intent on June 13, 2025, to cement emergency regulations limiting certain cannabis and hemp-derived products. The current regulations, which prioritize public health, especially for youth, were initially temporary but are now inching toward permanency. These protective measures are set to cease on September 23, 2025, unless made permanent.</p>
<p>Stakeholders are invited to voice their opinions during a 45-day public comment period which commenced on June 13, capped by a public hearing on July 28, 2025. These legislative moves underscore California's commitment to ensuring consumer safety in the burgeoning cannabis market.</p>
<H2>Pennsylvania House Approves Cannabis Legalization Bill</H2>
<p>On May 6, 2025, the Pennsylvania House of Representatives passed a landmark bill proposal to legalize cannabis for adults aged 21 and over. Introduced mere days earlier, the legislation gained swift momentum, moving through the House Health Committee before garnering a narrow approval with a 102-101 vote. This decisive yet divided vote highlighted distinct partisan lines, with Republicans opposed and Democrats advocating.</p>
<p>Despite the House's approval, the bill's journey halted in the Senate, demonstrating the ongoing legislative hurdles cannabis legalization faces in Pennsylvania. Nevertheless, this development marks a significant step toward broader acceptance and regulation within the state.</p>
<H2>Virginia Governor Vetoes Medical Cannabis Legislation</H2>
<p>Governor Glenn Youngkin of Virginia recently vetoed HB 1989, a bill aimed at refining medical cannabis regulations. The bill sought to enhance labeling standards and clarify delivery parameters for medical cannabis products. With the veto, Virginia's existing Cannabis Control Authority regulations remain in force, notably limiting delivery strictly to patient residences.</p>
<p>This decision reflects ongoing debates about accessibility and regulation of medical cannabis in Virginia. The outcome may adversely impact patient access, prompting continued discussions among stakeholders for a balanced approach to medical cannabis governance.</p>
<H2>Missouri Considers Enhanced Oversight on Hemp Products</H2>
<p>In February 2025, Missouri legislators advanced bills targeting the sale of hemp-derived products. Legislative bodies in both the House and Senate approved measures continuing the sale of products with hemp-derived THC in retail. However, they draw a regulatory line prohibiting intoxicating edibles and vapes from being sold outside licensed dispensaries.</p>
<p>Additionally, a proposed three-tier distribution system aims to streamline the market and ensure product quality and safety. Missouri's steps toward rigorous oversight reflect a growing trend among states to better manage hemp and cannabis-derived marketplaces.</p>
<p>#CannabisNews #CBDTrends #CannabisLegalization #HempInnovation #CannabisPolicy</p>